TOP2A and neoplasm: We validated the loss of TOP2A+ tumor cells, which we also observed by conventional differential expression analysis (Additional file 1: Fig. S9a), using in situ hybridization analysis of etoposide-treated slice cultures from a separate cohort (Additional file 1: Fig. S10).